Lucas Michon
Université Claude Bernard Lyon 1(FR)École Normale Supérieure de Lyon(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Lyon College(US)Centre Léon Bérard(FR)Intermutualist Agency(BE)Centre de Recherche en Cancérologie de Lyon(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Genetic factors in colorectal cancer, Pancreatic and Hepatic Oncology Research, Immune cells in cancer, Colorectal and Anal Carcinomas
Most-Cited Works
- → MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer(2022)67 cited
- → Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients(2022)63 cited
- → Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival(2021)35 cited
- → Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity(2021)34 cited
- → Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer(2022)32 cited
- → Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors